Skip to content

VYCOR MEDICAL, INC.: financial reference

Explore VYCOR MEDICAL, INC. financial histories from SEC filings, with original units, reporting periods, filing dates and downloadable source data.

Reported financial histories

Choose a measure to inspect its definition, complete selected history and filing provenance. Each row shows the latest period available for that selected concept and original unit. Separate currencies and reporting intervals remain separate rows. Coverage dates can differ between concepts. A recent capture does not imply recent accounting coverage; these amounts are not prices.

Latest periods by selected concept and original unit
MeasurePeriod startPeriod endValueUnitFiled
Total assetsAt date2015-12-312,022,731EUR2016-03-30
Total assetsAt date2025-12-31830,420USD2026-03-31
Total liabilitiesAt date2025-12-314,917,299USD2026-03-31
Stockholders equityAt date2015-12-311,145,722EUR2016-03-30
Stockholders equityAt date2025-12-31-4,086,879USD2026-03-31
Cash and cash equivalentsAt date2015-12-31347,477EUR2016-03-30
Cash and cash equivalentsAt date2025-12-3186,982USD2026-03-31
Net income or loss2015-01-012015-12-31-2,082,643EUR2016-03-30
Net income or loss2025-01-012025-12-31-72,426USD2026-03-31
Operating cash flow2015-01-012015-12-31-1,167,500EUR2016-03-30
Operating cash flow2025-01-012025-12-31-13,471USD2026-03-31
Capital expenditure payments2015-01-012015-12-31210,023EUR2016-03-30
Capital expenditure payments2025-01-012025-12-315,224USD2026-03-31
Revenue2015-01-012015-12-311,138,634EUR2016-03-30
Revenue2017-01-012017-12-311,384,971USD2018-03-30
Contract revenue excluding tax2025-01-012025-12-311,863,400USD2026-03-31
Financing cash flow2015-01-012015-12-31-85,300EUR2016-03-30
Financing cash flow2025-01-012025-12-31-812USD2026-03-31
Investing cash flow2015-01-012015-12-31-294,309EUR2016-03-30
Investing cash flow2025-01-012025-12-31-4,383USD2026-03-31
Retained earnings or deficitAt date2015-12-31-23,332,538EUR2016-03-30
Retained earnings or deficitAt date2025-12-31-33,648,856USD2026-03-31
Basic weighted-average shares2025-01-012025-12-3133,372,796shares2026-03-31
Diluted weighted-average shares2025-01-012025-12-3133,372,796shares2026-03-31
Basic earnings per share2025-01-012025-12-31-0.01USD/shares2026-03-31
Diluted earnings per share2025-01-012025-12-31-0.01USD/shares2026-03-31
Net property, plant and equipmentAt date2015-12-31521,105EUR2016-03-30
Net property, plant and equipmentAt date2025-12-31133,936USD2026-03-31
Share-based compensation expense2015-01-012015-12-31274,502EUR2016-03-30
Share-based compensation expense2025-01-012025-12-3148,838USD2026-03-31
Operating income or loss2015-01-012015-12-31-1,991,014EUR2016-03-30
Operating income or loss2025-01-012025-12-3133,900USD2026-03-31
Current assetsAt date2015-12-31858,693EUR2016-03-30
Current assetsAt date2025-12-31563,422USD2026-03-31
Interest expense2012-01-012012-12-31137,931USD2013-04-01
Current liabilitiesAt date2015-12-31877,009EUR2016-03-30
Current liabilitiesAt date2025-12-314,781,468USD2026-03-31
Current accounts payableAt date2015-12-31250,367EUR2016-03-30
Current accounts payableAt date2025-12-3184,755USD2026-03-31
Net current accounts receivableAt date2015-12-31106,340EUR2016-03-30
Net current accounts receivableAt date2025-12-31218,891USD2026-03-31
Operating expenses2015-01-012015-12-312,965,530EUR2016-03-30
Operating expenses2025-01-012025-12-311,527,207USD2026-03-31
Net inventoryAt date2015-12-31292,538EUR2016-03-30
Net inventoryAt date2025-12-31159,202USD2026-03-31
Gross profit2015-01-012015-12-31974,516EUR2016-03-30
Gross profit2025-01-012025-12-311,561,107USD2026-03-31
Selling, general and administrative expense2025-01-012025-12-311,457,723USD2026-03-31
Research and development expense2015-01-012015-12-3171,512EUR2016-03-30
Research and development expense2025-01-012025-12-319,963USD2026-03-31

Inspect the source

Entity
VYCOR MEDICAL, INC. / CIK 0001424768
Captured
2026-09-20T08:03:40.055Z
SEC response SHA-256
5a14e6ff2e4ebac913c15e977f951bb2964df57677e781dac80300af4dfd59db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001424768.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))